Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
Mark Levis
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
quizartinib
100%
Acute Myeloid Leukemia
49%
Receptor Protein-Tyrosine Kinases
28%
Drug Development
24%
Protein-Tyrosine Kinases
23%
Pharmacokinetics
19%
Therapeutics
8%